CompletedNCT00339222
Family Study of Melanoma in Italy
Studying Familial atypical multiple mole melanoma syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Cancer Institute (NCI)
- Principal Investigator
- Maria T Landi, M.D.National Cancer Institute (NCI)
- Enrollment
- 1708 enrolled
- Eligibility
- 10-100 years · All sexes
- Timeline
- 2001 – 2020
Study locations (7)
- Ospedale Maurizio Bufalini Cesena, Italy, Cessana, Italy
- University of Genoa, Genoa, Italy
- University of L'Aquila, L’Aquila, Italy
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
- Istituto Oncologico Veneto IRCCS University of Padua, Padua, Italy
- Hospital Clinic of Barcelona (Centre de Diagnostic Biomedic), Barcelona, Spain
- Instituto Valenciano de Oncologia, Valencia, Spain
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00339222 on ClinicalTrials.govOther trials for Familial atypical multiple mole melanoma syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06599619Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic NeviJohn Kirkwood
- RECRUITINGNCT04095195Registry of Subjects at Risk of Pancreatic CancerAssociazione Italiana per lo Studio del Pancreas
- RECRUITINGNCT05446155BioMEL- Diagnostic and Prognostic Factors in Melanoma.Region Skane
- RECRUITINGNCT00040352Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of MelanomaNational Cancer Institute (NCI)
See all trials for Familial atypical multiple mole melanoma syndrome →